Company Analysis

Brainsway Ltd. (BWAY)

Nasdaq: BWAY · Surgical & Medical Instruments & Apparatus · Jerusalem, IL · filing with the SEC since 2011
Grade6.2
◀ Past 5.9● Present 5.7▶ Future 7.2
1 est.
The companyfiscal 2024, as filed
Revenue$41.0M+29.0%
Net income$2.9M+169.6%
Earnings per share$0.05+138.5%
Operating cash flow$10.3M+702.0%
Cash$69.3M+559.2%
Debtn/a
Shareholders’ equity$62.3M+49.9%
Shares, diluted34.0M+2.5%
Return on equity4.7%
The recordfrom its filings
Filings in 202659
Newest filingNov 10 · 6-K
Annual reportApr 20, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted16
Filer categoryAccelerated filer
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
1718192021222324
As filed, in USD. Nothing here is a forecast.

News

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton BWAY · research, not advice